Scalp cooling for cancer patients

Scalp cooling is changing the face of cancer, by helping thousands of people keep their hair while undergoing treatment for chemotherapy.

Cancer affects people in different ways, but one of the most traumatic side effects of chemotherapy is hair loss. The process can make a patient feel like they are losing control of their body and their appearance, at what is already an extremely difficult time in their life. Chemotherapy does not have to mean hair loss though, as many people across the UK and throughout the world are finding out after using a pioneering scalp cooling technology. 

Developed in Huddersfield, the Paxman Scalp Cooling System is changing the face of cancer, by helping thousands of people keep their hair while undergoing treatment for chemo.1 Scalp cooling (the cold cap) can be used with all solid tumour cancers that are treated with chemotherapy drugs such as taxanes (e.g. docetaxel), alkylating agents (e.g. cyclophosphamide) and anthracyclines/DNA intercalating agents (e.g. doxorubicin). These drugs target rapidly dividing cells and the matrix keratinocytes, which results in hair loss. 

Scalp cooling cannot be used with the following conditions: 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

IDSc Annual Conference 2024

Hilton Birmingham Metropole Hotel
26th - 27th November 2024

IV Forum 2024

Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024

The AfPP Roadshow - Leeds

TBA, Leeds
7th December 2024

Decontamination and Sterilisation 2025 Conference and Exhibition

The National Conference Centre, Birmingham
11th February 2025

The Fifth Annual Operating Theatres Show 2025

Kia Oval, London
11th March 2025, 9:00am - 4:00pm

Infection Prevention and Control 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th – 30th April 2025